Ducommun Incorporated $DCO Shares Sold by Gamco Investors INC. ET AL
Gamco Investors INC. ET AL cut its Ducommun Incorporated (NYSE:DCO) stake by 13.1% in Q1, selling 67,639 shares to hold 449,461 shares, about 2.98% worth $54.8M, per its SEC 13F. The article also cites insider sales and analyst target changes. Ducommun reported Q earnings of $0.75 EPS and $209.0M revenue (May 12).
How this was made
The 30-second read
Why it matters
For trading, the only potentially decision-relevant elements are (1) the direction of institutional positioning in Q1 and (2) the magnitude/direction of sell-side target changes. However, there is no new earnings print, guidance update, contract award, or regulatory action in the text.
Market read
This is mainly positioning and research-update flow for DCO, with no fresh fundamental catalyst described.
What to watch
The article does not provide the thesis behind target changes or quantify backlog/order trends, so traders should not over-weight the target revisions without corroborating operational updates.
Background
The piece is a MarketBeat-style alert summarizing Ducommun’s institutional ownership (13F) changes, insider sales (Form 4-style transactions), and recent analyst rating/price-target updates, plus a recap of the latest quarterly results.
Ticker impact
Ducommun (DCO) is the subject, with the article citing Q1 13F stake reduction by Gamco and multiple analyst price-target changes.
Likely limited near-term impact; any move would be sentiment-driven around analyst target changes rather than a fresh catalyst.
The newest concrete disclosures are institutional ownership changes and analyst target revisions, while the article does not introduce new guidance, earnings results, or a transaction affecting Ducommun’s cash flows.
Market effects
Aerospace supplier sentiment may be modestly supported by analyst target increases, but the article provides no new sector datapoint beyond positioning.
No clear regional transmission; this is US-listed single-name positioning and research updates.
Limited global relevance; no international regulatory or contract developments are disclosed.
Counterpoint
Insider sales and a 13F stake reduction can indicate reduced conviction, so the analyst target increases may not translate into near-term outperformance.
Key entities
- companyDucommun Incorporated
US aerospace supplier; subject of the article with cited 13F changes, insider sales, and analyst target revisions.
- institutional_investorGamco Investors INC. ET AL
Reportedly reduced its Ducommun stake by 13.1% in Q1 per the article’s 13F reference.
- analyst_firmCitigroup
Raised Ducommun price target from $167 to $216 and reiterated buy (per article).
- analyst_firmB. Riley Financial
Increased Ducommun price objective from $155 to $187 and reiterated buy (per article).
- analyst_firmTruist Financial
Raised Ducommun target price from $136 to $150 and reiterated buy (per article).
